do glp 1 drugs cause cancer and Risk of pancreatic associated with GLP-1 receptor agonist therapy GLP-1 drugs cancer? – The effect of GLP-1R agonists

Zinc Although more research needs to be done, researchers have started (6) to look at the relationship between zinc deficiency and the prevalence of vitiligo with studies showing (7) that zinc deficiency is common among those with this condition

Animal studies place the plasma half-life at approximately 2 hours after subcutaneous injection

Finally, beware of compounded GLP-1 drugs, which became popular during a GLP-1 drug shortage starting in 2022

But those taking a GLP-1 for weight loss may think about reducing their dose or even stopping completely once they reach their goal weight

3 One study (an extension of the original STEP-1 trial) also showed that participants regained two-thirds of their weight after discontinuing semaglutide, suggesting that maintaining weight loss may require long-term use